Strategic IP & Capital Risk Audit
A fixed-fee diagnostic of your technology, IP, and capital exposure. From $25,000 — and yours to keep.
Most technology risk presented to boards and diligence teams is described, not quantified. The audit exists to put names and numbers on it: which systems carry regulatory exposure, which patents actually defend the moat, and where capital spend is not returning.
Manuel examined 221 patents across six years at the USPTO and qualified as a Patent Agent by federal examination. He carried $400 million in commercial credit authority at Ford Motor Credit through the 2008 collapse with zero defaults. Your IP and capital risk get read by someone who has been personally accountable for both.
What you get
- A written report naming every material technology, IP, and regulatory risk — in language a board or investment committee can read
- A patent and IP position review: what is defensible, what is exposed, what is unmonetized
- A capital review: whether software, simulation, and data-science spend is driving measurable bottom-line efficiency
- A prioritized action plan — what to fix now, what to fix this quarter, what to leave alone
- A working session to walk the findings with your board, deal team, or leadership
Best for private equity sponsors conducting pre-acquisition or post-merger due diligence, and for boards that want an independent read. Fixed fee from $25,000 depending on scope. If we stop there, you keep the report and every finding in it.
Retain XZeus advisory services.
Request an initial consultation for board advisory, fractional CAIO/CTO leadership, IP and capital risk audits, or venture strategy. No pitch deck — if XZeus isn't the right fit, Manuel will tell you on the call.
Book a free 30-minute consultationOr write directly: mp@xzeus.ai